Circulation Research. 2005;96:355-362
Published online before print January 6, 2005,
doi: 10.1161/01.RES.0000155331.09458.A7
(Circulation Research. 2005;96:355.)
© 2005 American Heart Association, Inc.
A Defect of Neuronal Nitric Oxide Synthase Increases Xanthine Oxidase-Derived Superoxide Anion and Attenuates the Control of Myocardial Oxygen Consumption by Nitric Oxide Derived From Endothelial Nitric Oxide Synthase
Shintaro Kinugawa,
Harer Huang,
Ziping Wang,
Pawel M. Kaminski,
Michael S. Wolin,
Thomas H. Hintze
From the Department of Physiology, New York Medical College, Valhalla.
Correspondence to Thomas H. Hintze, PhD, Professor, Department of Physiology New York Medical College Valhalla, NY 10595. E-mail Thomas_Hintze{at}nymc.edu
Endothelial nitric oxide synthase (eNOS) plays an important role in the control of myocardial oxygen consumption (MVO2) by nitric oxide (NO). A NOS isoform is present in cardiac mitochondria and it is derived from neuronal NOS (nNOS). However, the role of nNOS in the control of MVO2 remains unknown. MVO2 in left ventricular tissues from nNOS–/– mice was measured in vitro. Stimulation of NO production by bradykinin or carbachol induced a significant reduction in MVO2 in wild-type (WT) mice. In contrast to WT, bradykinin- or carbachol-induced reduction in MVO2 was attenuated in nNOS–/–. S-methyl-L-thiocitrulline, a potent isoform selective inhibitor of nNOS, had no effect on bradykinin-induced reduction in MVO2 in WT. Bradykinin-induced reduction in MVO2 in eNOS–/– mice, in which nNOS still exists, was also attenuated. The attenuated bradykinin-induced reduction in MVO2 in nNOS–/– was restored by preincubation with Tiron, ascorbic acid, Tempol, oxypurinol, or SB203850, an inhibitor of p38 kinase, but not apocynin. There was an increase in lucigenin-detectable superoxide anion (O2–) in cardiac tissues from nNOS–/– compared with WT. Tempol, oxypurinol, or SB203850 decreased O2– in all groups to levels that were not different from each other. There was an increase in phosphorylated p38 kinase normalized by total p38 kinase protein level in nNOS–/– compared with WT mice. These results indicate that a defect of nNOS increases O2– through the activation of xanthine oxidase, which is mediated by the activation of p38 kinase, and attenuates the control of MVO2 by NO derived from eNOS.
Key Words: endothelial nitric oxide synthase • neuronal nitric oxide synthase • superoxide anion • p38 • oxygen consumption
This article has been cited by other articles:
|
|
|
|
 
D. R. Gonzalez, A. V. Treuer, and R. A. Dulce
Neuronal nitric oxide synthase in heart mitochondria: a matter of life or death
J. Physiol.,
June 15, 2009;
587(12):
2719 - 2720.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-L. Balligand, O. Feron, and C. Dessy
eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues
Physiol Rev,
April 1, 2009;
89(2):
481 - 534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wang, M. J. Kohr, C. J. Traynham, D. G. Wheeler, P. M. L. Janssen, and M. T. Ziolo
Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban
Am J Physiol Cell Physiol,
June 1, 2008;
294(6):
C1566 - C1575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. H. Zhang, M. H. Zhang, C. E. Sears, K. Emanuel, C. Redwood, A. El-Armouche, E. G. Kranias, and B. Casadei
Reduced Phospholamban Phosphorylation Is Associated With Impaired Relaxation in Left Ventricular Myocytes From Neuronal NO Synthase-Deficient Mice
Circ. Res.,
February 1, 2008;
102(2):
242 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Gonzalez, F. Beigi, A. V. Treuer, and J. M. Hare
Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes
PNAS,
December 18, 2007;
104(51):
20612 - 20617.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. D. Wadley, J. Choate, and G. K. McConell
NOS isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle
J. Physiol.,
November 15, 2007;
585(1):
253 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Yang and L. A. Barouch
Leptin Signaling and Obesity: Cardiovascular Consequences
Circ. Res.,
September 14, 2007;
101(6):
545 - 559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Seddon, A. M. Shah, and B. Casadei
Cardiomyocytes as effectors of nitric oxide signalling
Cardiovasc Res,
July 15, 2007;
75(2):
315 - 326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Casadei
The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function
Exp Physiol,
November 1, 2006;
91(6):
943 - 955.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev.,
March 1, 2006;
58(1):
87 - 114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-L. Balligand
"La Donna e Mobile...": Is Cardiac Neuronal Nitric Oxide Synthase Such a Disconcerting Enzyme?
Circulation,
December 13, 2005;
112(24):
3668 - 3671.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dawson, C. A. Lygate, M.-H. Zhang, K. Hulbert, S. Neubauer, and B. Casadei
nNOS Gene Deletion Exacerbates Pathological Left Ventricular Remodeling and Functional Deterioration After Myocardial Infarction
Circulation,
December 13, 2005;
112(24):
3729 - 3737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Saraiva, K. M. Minhas, S. V.Y. Raju, L. A. Barouch, E. Pitz, K. H. Schuleri, K. Vandegaer, D. Li, and J. M. Hare
Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium
Circulation,
November 29, 2005;
112(22):
3415 - 3422.
[Abstract]
[Full Text]
[PDF]
|
|
|
